title: [Role of radiotherapy in the management of node-positive prostate cancer].
abstract: Node-positive prostate cancer patients represent a small proportion of all prostate cancers for whom limited prospective information is available. Most retrospective or cohort data strongly suggest however that radiotherapy combined with androgen-depriving therapies is the preferable treatment in this setting. Only randomized clinical trials would be able to better define both radiotherapy (dose? volume? fractionation?) and androgen-depriving therapies (duration? role of novel androgen-depriving therapy?) modalities.
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France. Electronic address: stephane.supiot@ico.unicancer.fr.
authors: S
authors: S
authors: Supiot
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors: M
authors: M
authors: Doré
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors: E
authors: E
authors: Rio
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors: P
authors: P
authors: Cellier
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors: N
authors: N
authors: Mesguez-Nebout
authors: Département de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France.
authors: A
authors: A
authors: Goineau
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant
chemical_list: D000726:Androgen Antagonists
keywords: Adénome de la prostate; Androgen depriving therapy; Cancer de la prostate métastatique; Hormonetherapy; Hormonothérapie; Irradiation; Metastatic prostate cancer; N1; Oligometastases; Oligométastases; Pelvis; Prostate adenocarcinoma; cN1; pN1